Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Armando CaballeroLázaro M FilgueiraJulio BetancourtNaivy SánchezCarlos HidalgoAlberto RamírezAlejandro MartinezRolando E DespaigneAlberto EscalonaHenrry DiazElio MeriñoLilia M OrtegaUlises CastilloMayra RamosDanay SaavedraYanelda GarcíaGeydi LorenzoMeylán CepedaMaylén ArencibiaLeticia CabreraMilagros DomecqDaymys EstévezCarmen ValenzuelaPatricia LorenzoLizet SánchezZaima MazorraKalet LeónTania Crombet RamosPublished in: Clinical & translational immunology (2020)
The opportune administration of itolizumab might interrupt the hyperinflammatory cascade and prevent COVID-19 morbidity and mortality.